Reflect on the provided data and tweets to anticipate if the closing price of $gild is going to increase or decrease at 2017-03-15. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-01,0.9,1.1,-0.2,-0.4,-0.4,-0.1,-0.5,-1.9,-0.6,-0.1,0.2
2017-03-02,-0.8,0.5,-0.8,0.5,0.5,-0.3,-0.9,-2.1,-1.2,-0.6,-0.4
2017-03-03,-0.1,0.1,-0.7,0.3,0.3,-0.4,-1.1,-1.9,-1.6,-0.9,-0.7
2017-03-06,0.6,0.7,-0.6,-0.9,-0.9,0.4,-0.2,-0.6,-0.9,-0.1,0.1
2017-03-07,0.8,1.4,-0.3,-1.6,-1.6,1.6,1.4,1.1,0.4,1.3,1.6
2017-03-08,-1.0,0.4,-1.2,1.0,1.0,0.5,0.5,0.3,-0.8,0.2,0.6
2017-03-09,1.2,1.3,-0.8,-1.9,-1.9,1.8,2.3,2.1,1.2,1.8,2.4
2017-03-10,0.6,0.6,-1.1,-0.3,-0.3,1.3,2.3,2.2,1.7,1.9,2.5
2017-03-13,0.3,0.4,-0.8,-0.1,-0.1,0.9,2.1,2.1,1.9,1.8,2.5
2017-03-14,-0.5,0.5,-0.5,-0.5,0.3,0.4,1.5,1.8,1.7,1.3,2.1

2017-03-01: $gild weekly 70c buyer early, but couldn't get it into the gap. keep a eye on this one. |AT_USER AT_USER yes, but the pr they issued is to pump the price. $gild would never issue that.|scan results - 
2017-03-02: valeant: probably worthless, or risky but attractive now?  $abbv $abt $agn $endp $gild $myl $prgo $teva $vrx|rt AT_USER so $gild didnt buy anything with $xbi in the 40-50s .... waiting for lower pps .
2017-03-03: rt AT_USER $gild weekly. initial follow through higher from the inside-inside weeks $ibb |rt AT_USER tgif - yellen and the people's congress #fomc $tza $gild $spy $dia #futures --  |rt AT_USER tgif - 
2017-03-04: AT_USER $gild complain basically after other lower price entry, they can't easily reset list price w/o changing existing contracts.|gilead: oncology acquisition incoming  $glpg $incy $nvs $rhhby $gild
2017-03-05: rt AT_USER AT_USER i've seen $gild for $incy countless times but never $pfe for them. would complement xeljanz and other inflamm¡­|rt AT_USER $gild or $bmrn? |rt AT_USER $incy too big for $gild now, a
2017-03-06: 5 things for #pharma #marketers to know: mon., mar. 6 $gild #drugprices $googl #ai #cancer $sny $regn #fda $agn¡­ |AT_USER $gild keeps on delivering superb results from its pipeline. don't worry keep 
2017-03-07: rbc hints at potential m&amp;a for kite pharma $gild $kite $nvs  via AT_USER|$gild $gild |rt AT_USER fiercebiotech¡¯s 2016 rotten tomatoes:  $juno $nvs $arwr $gild $nwbo and more|trump tweets about a 
2017-03-08: AT_USER AT_USER AT_USER AT_USER what i in roi? $gild bought phrmset for $11b, but hep c drugs r&amp;d was just $500m.|$esrx fires back at $gild |rt AT_USER trending: in quick rebuttal, express scripts
2017-03-09: rt AT_USER bay area cos have $500b+ overseas. will AT_USER help bring it home?  $aapl $v $gild $cs¡­|gild potential swing trade - $gild chart |gild potential swing trade $gild |rt AT_USER classic case
2017-03-10: incyte pops on continued gilead takeout speculation $incy $gild  $tsro AT_USER AT_USER AT_USER|$incy baker bros 50% gain ytd for $1.7b* unrealized gain - they'd sell to $gild or whoever the fk that wa
2017-03-11: gilead sciences, inc. $gild rating reiterated by barclays plc |gilead sciences's outperform rating reiterated at barclays plc. $90.00 pt.  $gild #gild|gilead has multiple prospects if it decides to pu
2017-03-12: $gild $incy rumor or not, friday's reaction shows acquisition of literally any company with a decent onc-driven pipepine will lift up $gild|$ibb $gild should be clear to everyone by now that gild got 
2017-03-13: $gild:us  incyte corp. (incy) spiked to a new high on gilead rumors #gilead sciences inc   #nasdaq|$gild $incy AT_USER AT_USER |what a combined gilead and incyte would look like $gild $incy  AT_USER A
2017-03-14: rt AT_USER tuesday - the #trumpdon'tcare health plan fails america $spy $met $gild $lly #esrx --  |rt AT_USER tuesday - the #trumpdon'tcare health plan fails america $spy $met $gild $lly #esrx --  |rt
Answer:
Rise